Associated Papers
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y et al.
Leukemia, 2025
40259101 (PubMed )
Supplement: 41375_2025_2625_MOESM2_ESM.xlsx › Sheet5
Inactivating CUX1 mutations promote tumorigenesis.
Wong CC et al.
Nature Genetics, 2014
24316979 (PubMed )
Supplement: NIHMS55610-supplement-2.xlsx › Sup_table_3
Select a paper to view details